| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/10/2009 | CA2639512A1 Nasal rinse additive |
| 03/10/2009 | CA2501584C The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus |
| 03/10/2009 | CA2468649C Adenosine a2a receptor antagonists |
| 03/10/2009 | CA2449856C Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells |
| 03/10/2009 | CA2430288C A composition improved in the solubility or oral absorbability |
| 03/10/2009 | CA2415068C Oral compositions comprising antimicrobial agents |
| 03/10/2009 | CA2394602C New modulators of dopamine neurotransmission |
| 03/10/2009 | CA2379649C The use of conjugated linoleic acid for the selective inhibition of cyclooxygenase-2 |
| 03/10/2009 | CA2377233C Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof |
| 03/10/2009 | CA2368418C 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
| 03/10/2009 | CA2363973C Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
| 03/10/2009 | CA2358436C Polyunsaturated fatty acid derivatives and their use |
| 03/10/2009 | CA2352614C Lak activity-screening materials containing lentinus extract of edodes mycelium and lak activity-screening methods using the extract |
| 03/10/2009 | CA2347773C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 03/10/2009 | CA2345069C 2-phenylpyran-4-one derivatives |
| 03/10/2009 | CA2342210C Thiazoline acid derivatives |
| 03/10/2009 | CA2336853C Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| 03/10/2009 | CA2301057C A method of administering liposomal encapsulated taxane |
| 03/10/2009 | CA2300049C Compositions, apparatus and methods for facilitating surgical procedures |
| 03/10/2009 | CA2289851C Compounds and methods for the inhibition of the expression of vcam-1 |
| 03/10/2009 | CA2285263C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 03/10/2009 | CA2252896C Inactivation resistant factor viii |
| 03/10/2009 | CA2197677C A method of selectively destroying neoplastic cells |
| 03/05/2009 | WO2009029888A2 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
| 03/05/2009 | WO2009029885A1 Treatment of autoimmune disease |
| 03/05/2009 | WO2009029844A1 Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods |
| 03/05/2009 | WO2009029801A2 Selective cytopheresis devices and related methods thereof |
| 03/05/2009 | WO2009029762A2 Farnesylamine inhibitors of the visual cycle |
| 03/05/2009 | WO2009029729A1 Amino tricyclic-nucleoside compounds, compositions, and methods of use |
| 03/05/2009 | WO2009029727A1 Cannabinoid receptor targeted agent |
| 03/05/2009 | WO2009029717A1 Carbamate stereoisomer |
| 03/05/2009 | WO2009029692A1 Methods for improving healing of an oral lesion using a glycerophosphate salt |
| 03/05/2009 | WO2009029681A2 Micrornas for inhibiting viral replication |
| 03/05/2009 | WO2009029656A1 METHODS FOR INHIBITING TGF-β |
| 03/05/2009 | WO2009029632A1 Therapeutic isoxazole compounds |
| 03/05/2009 | WO2009029625A1 4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors |
| 03/05/2009 | WO2009029622A2 Antiviral drugs for treatment of arenavirus infection |
| 03/05/2009 | WO2009029618A1 Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect |
| 03/05/2009 | WO2009029617A1 Diarylamine-substituted quinolones useful as inducible nitric oxide synthase inhibitors |
| 03/05/2009 | WO2009029609A1 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 03/05/2009 | WO2009029592A1 Heterobicyclic-substituted quinolones useful as nitric oxide synthase inhibitors |
| 03/05/2009 | WO2009029499A1 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds |
| 03/05/2009 | WO2009029480A1 Formulations of px compounds |
| 03/05/2009 | WO2009029473A1 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| 03/05/2009 | WO2009029439A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 03/05/2009 | WO2009029384A2 Compounds for the treatment of hepatitis c |
| 03/05/2009 | WO2009029375A1 Novel inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | WO2009029293A2 Nucleic acid compounds for inhibiting myc gene expression and uses thereof |
| 03/05/2009 | WO2009029257A1 Disubstituted alkyl-8-azabicyclo [3.2.1.] octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | WO2009029256A1 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 03/05/2009 | WO2009029253A1 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | WO2009029252A1 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | WO2009029214A1 Isoquinolone derivatives as phosphodiesterase 10 inhibitors |
| 03/05/2009 | WO2009029206A1 Chemotherapeutic for inducing an msh2-dependent apoptotic pathway |
| 03/05/2009 | WO2009029069A1 Methods of inhibiting or suppressing cellular proliferation |
| 03/05/2009 | WO2009028989A2 Overweight treatment method |
| 03/05/2009 | WO2009028983A1 Use of naphthalene derivatives in form of agents for treating oncological diseases |
| 03/05/2009 | WO2009028972A1 A new inhibitor of dd-peptidase and its use as antibiotic or anticancer drug |
| 03/05/2009 | WO2009028839A1 Pharmaceutical composition for preventing or treating bone diseases comprising licochalcone a |
| 03/05/2009 | WO2009028707A1 Inhibitor of ischemic disorders |
| 03/05/2009 | WO2009028674A1 Latanoprost-containing aqueous pharmaceutical composition |
| 03/05/2009 | WO2009028655A1 Heterocyclic compound and use thereof |
| 03/05/2009 | WO2009028650A1 Emulsion-type external preparation, and method for production thereof |
| 03/05/2009 | WO2009028649A1 Method for reduction in volume of solid preparation having high amino acid content |
| 03/05/2009 | WO2009028643A1 Method for production of carotenoid |
| 03/05/2009 | WO2009028631A1 Agent for promoting corneal endothelial cell adhesion |
| 03/05/2009 | WO2009028629A1 Heterocyclic compound and use thereof |
| 03/05/2009 | WO2009028618A1 Piperidine derivative |
| 03/05/2009 | WO2009028598A1 Sustained release preparation and process for production thereof |
| 03/05/2009 | WO2009028588A1 Polycyclic compound |
| 03/05/2009 | WO2009028581A1 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| 03/05/2009 | WO2009028580A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 03/05/2009 | WO2009028575A1 Activator for blood coagulation factor vii promoter and utilization of the same |
| 03/05/2009 | WO2009028573A1 Use of ribavirin in blood coagulation disorder |
| 03/05/2009 | WO2009028559A1 Water-absorbing polymer particle and method for producing water-absorbing polymer particle |
| 03/05/2009 | WO2009028543A1 Substituted pyrazole derivative |
| 03/05/2009 | WO2009028521A1 Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis |
| 03/05/2009 | WO2009028495A1 Agent for fungal dermatitis |
| 03/05/2009 | WO2009028457A1 Therapeutic agent for nonalcoholic steatohepatitis |
| 03/05/2009 | WO2009028387A1 Therapeutic agent for cancer with resistance to protease inhibitor |
| 03/05/2009 | WO2009028220A1 Collagen production promoter |
| 03/05/2009 | WO2009028150A1 Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent |
| 03/05/2009 | WO2009027994A2 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 03/05/2009 | WO2009027965A1 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
| 03/05/2009 | WO2009027956A2 Syndrome x composition and method of lowering blood pressure and glycemic index |
| 03/05/2009 | WO2009027955A2 Detoxification composition and method of detoxifying the body |
| 03/05/2009 | WO2009027954A1 Appetite suppressant composition and method of appetite suppression |
| 03/05/2009 | WO2009027844A2 Crf conjugates with extended half-lives |
| 03/05/2009 | WO2009027823A2 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. |
| 03/05/2009 | WO2009027820A2 Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
| 03/05/2009 | WO2009027811A2 Polymorphs of 3- ( ( (4-tert-butyl-benzyl) - (pyridine-3-sulfonyl) -amino) -methyl) -phenoxy) -acetic acid sodium salt or a hydrate thereof and methods for making the same |
| 03/05/2009 | WO2009027786A2 Matrix dosage forms of varenicline |
| 03/05/2009 | WO2009027766A2 New crystalline solid forms of o-desvenlafaxine base |
| 03/05/2009 | WO2009027762A2 Liquid dosage forms of fluoroquinolone antibiotics or salt thereof for ophthalmic, otic and nasal administration |
| 03/05/2009 | WO2009027746A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 03/05/2009 | WO2009027736A2 2,4 diaminopyrimid'lnes for the treatment of myeloproliferative disorders and cancer |
| 03/05/2009 | WO2009027733A1 (2-pyridin-3-ylimidazo[1,2-b]pyridazin-6-yl) urea derivatives as antibacterial agents |
| 03/05/2009 | WO2009027732A1 5-6-bicyclic heteroaromatic compounds with antibacterial activity |
| 03/05/2009 | WO2009027730A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | WO2009027697A2 Non-aqueous pharmaceutical compositions |